Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: DRUG: vorinostat
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: National Cancer Institute (NCI)